Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin

A longstanding question is how influenza virus evolves to escape human immunity, which is polyclonal and can target many distinct epitopes. Here, we map how all amino-acid mutations to influenza’s major surface protein affect viral neutralization by polyclonal human sera. The serum of some individuals is so focused that it selects single mutations that reduce viral neutralization by over an order of magnitude. However, different viral mutations escape the sera of different individuals. This individual-to-individual variation in viral escape mutations is not present among ferrets that have been infected just once with a defined viral strain. Our results show how different single mutations help influenza virus escape the immunity of different members of the human population, a phenomenon that could shape viral evolution and disease susceptibility.

[1]  C. Stuart-harris,et al.  A NEUROTROPIC STRAIN OF HUMAN INFLUENZA VIRUS , 1939 .

[2]  A. S. Beare,et al.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses , 1972, Epidemiology and Infection.

[3]  R. Couch Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. , 1975, Developments in biological standardization.

[4]  Couch Rb Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. , 1975 .

[5]  G. Air,et al.  Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. , 1979, Virology.

[6]  R. Webster,et al.  Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule , 1979, Nature.

[7]  R. Webster,et al.  Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. , 1980, Virology.

[8]  R. Webster,et al.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies , 1981, Nature.

[9]  I. Wilson,et al.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation , 1981, Nature.

[10]  T. Hoskins,et al.  Christ's Hospital 1978–79: An account of two outbreaks of influenza A H1N1 , 1982 .

[11]  M. Lubeck,et al.  Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. , 1982, Virology.

[12]  J. Yewdell,et al.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) , 1982, Cell.

[13]  R B Couch,et al.  Immunity to influenza in man. , 1983, Annual review of microbiology.

[14]  J. Yewdell,et al.  Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies , 1986, Journal of virology.

[15]  B. Murphy,et al.  Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum , 1987, Journal of clinical microbiology.

[16]  Tokiko Watanabe,et al.  Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Webster,et al.  A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[19]  Arthur Chun-Chieh Shih,et al.  Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution , 2007, Proceedings of the National Academy of Sciences.

[20]  L. Jost Partitioning diversity into independent alpha and beta components. , 2007, Ecology.

[21]  James E. Crowe,et al.  Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors , 2008, Nature.

[22]  J. D. Capra,et al.  Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen , 2009, Nature Protocols.

[23]  Rahul Raman,et al.  Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift , 2009, Science.

[24]  G. Whittaker,et al.  Modifications to the Hemagglutinin Cleavage Site Control the Virulence of a Neurotropic H1N1 Influenza Virus , 2010, Journal of Virology.

[25]  David Baltimore,et al.  Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance , 2010, Science.

[26]  G. Air,et al.  Immunodominance of Antigenic Site B over Site A of Hemagglutinin of Recent H3N2 Influenza Viruses , 2012, PloS one.

[27]  J. Plotkin,et al.  Immune history shapes specificity of pandemic H1N1 influenza antibody responses , 2013, The Journal of experimental medicine.

[28]  D. Burke,et al.  Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution , 2013, Science.

[29]  J. Bloom,et al.  A Mutant Influenza Virus That Uses an N1 Neuraminidase as the Receptor-Binding Protein , 2013, Journal of Virology.

[30]  S. Nelson,et al.  High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution , 2014, Scientific Reports.

[31]  C. A. Russell,et al.  Antibody landscapes after influenza virus infection or vaccination , 2014, Science.

[32]  J. Bloom,et al.  Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season , 2014, Proceedings of the National Academy of Sciences.

[33]  Y. Iba,et al.  Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus , 2014, Nature Communications.

[34]  Trevor Bedford,et al.  Integrating influenza antigenic dynamics with molecular evolution , 2013, eLife.

[35]  An Experimentally Determined Evolutionary Model Dramatically Improves Phylogenetic Fit , 2014, Molecular biology and evolution.

[36]  M. Lässig,et al.  A predictive fitness model for influenza , 2014, Nature.

[37]  S. Hensley,et al.  Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. , 2015, Cell reports.

[38]  Patrick C. Wilson,et al.  Immune history profoundly affects broadly protective B cell responses to influenza , 2015, Science Translational Medicine.

[39]  Trevor Bedford,et al.  nextflu: real-time tracking of seasonal influenza virus evolution in humans , 2015, Bioinform..

[40]  D. Cummings,et al.  Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.

[41]  Min Huang,et al.  High Preexisting Serological Antibody Levels Correlate with Diversification of the Influenza Vaccine Response , 2015, Journal of Virology.

[42]  R. Daniels,et al.  Focused antibody response to influenza linked to antigenic drift. , 2015, The Journal of clinical investigation.

[43]  J. Wrammert,et al.  Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. , 2015, The Journal of clinical investigation.

[44]  Brantley R. Herrin,et al.  Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity , 2015, eLife.

[45]  Jesse D. Bloom,et al.  Software for the analysis and visualization of deep mutational scanning data , 2015, bioRxiv.

[46]  Baoshan Zhang,et al.  Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination , 2016, Nature Medicine.

[47]  James O. Lloyd-Smith,et al.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016, Science.

[48]  Michael B. Doud,et al.  Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin , 2016, Viruses.

[49]  Trevor Bedford,et al.  Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses , 2015, Proceedings of the National Academy of Sciences.

[50]  Hongmei Yang,et al.  Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine‐mediated immune protection , 2016, Immunology.

[51]  D. Burke,et al.  Selection of antigenically advanced variants of seasonal influenza viruses , 2016, Nature Microbiology.

[52]  Judith M. Fonville,et al.  Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection , 2015, The Journal of infectious diseases.

[53]  Caitlin E. Mullarkey,et al.  Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus , 2016, Proceedings of the National Academy of Sciences.

[54]  G. Lal,et al.  Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection , 2017, PLoS pathogens.

[55]  S. Hensley,et al.  Immune history and influenza virus susceptibility. , 2017, Current opinion in virology.

[56]  S. Kent,et al.  Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults , 2017, The Journal of infectious diseases.

[57]  J. Tregoning,et al.  Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre , 2017, Front. Microbiol..

[58]  J. Bloom,et al.  Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody. , 2017, Cell host & microbe.

[59]  Seth J. Zost,et al.  Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains , 2017, Proceedings of the National Academy of Sciences.

[60]  Michael B. Doud,et al.  Complete mapping of viral escape from neutralizing antibodies , 2016, bioRxiv.

[61]  I. Wilson,et al.  A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus. , 2017, Journal of molecular biology.

[62]  Matthew Angel,et al.  Defining B Cell Immunodominance to Viruses , 2017, Nature Immunology.

[63]  Michael B. Doud,et al.  How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin , 2018, Nature Communications.

[64]  P. Wilson,et al.  Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance , 2018, Journal of Virology.

[65]  Nicole M. Bouvier,et al.  Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance , 2018, The Journal of clinical investigation.

[66]  Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo , 2018, Journal of Virology.

[67]  V. Simon,et al.  Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice , 2018, Journal of Virology.

[68]  T. Bedford,et al.  Seasonal influenza circulation patterns and projections for Feb 2018 to Feb 2019 , 2018, bioRxiv.

[69]  Trevor Bedford,et al.  Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants , 2018, Proceedings of the National Academy of Sciences.

[70]  Trevor Bedford,et al.  Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.

[71]  R. Lerner,et al.  A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site , 2018, Nature Communications.

[72]  Alexander S. Rose,et al.  NGLview–interactive molecular graphics for Jupyter notebooks , 2018, Bioinform..

[73]  F. Krammer The human antibody response to influenza A virus infection and vaccination , 2019, Nature Reviews Immunology.

[74]  Henry A. Utset,et al.  Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. , 2019, Cell host & microbe.

[75]  J. Bloom,et al.  Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans , 2019, bioRxiv.

[76]  J. Peiris,et al.  Age-specific differences in the dynamics of protective immunity to influenza , 2018, Nature Communications.

[77]  A. Monto,et al.  Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season. , 2019, The Journal of infectious diseases.

[78]  J. Yewdell,et al.  Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies , 2018, bioRxiv.

[79]  George Georgiou,et al.  Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations. , 2019, Cell host & microbe.

[80]  J. Bloom,et al.  Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin , 2019, bioRxiv.

[81]  Ha T. Nguyen,et al.  Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018 , 2019, Scientific Reports.

[82]  J. Bloom,et al.  An Antigenic Atlas of HIV‐1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes , 2019, Immunity.